| Discover how AI and RWD are transforming drug development by optimizing clinical trial protocols, enhancing recruitment, ...

During a recent panel discussion sponsored by Purdue University, industry leaders explain how the technology is revolutionizing drug development and production ...

AI is now a key business consideration. BI's series AI in Action explores how company leaders create infrastructure and ...

As per Vantage Market Research, the Global Artificial Intelligence in the Drug Discovery Market has been steadily growing ...

Recursion Pharmaceuticals' stock is soaring today on news the FDA is planning on phasing out some animal testing, replacing ...

RedChip Companies will air interviews with Bullfrog AI Holdings, Inc. (Nasdaq:BFRG) and Connect Biopharma Holdings Limited (Nasdaq:CNTB) and on the RedChip Small Stocks, Big Money™ show, a sponsored ...

QuantHealth, an AI-powered drug development platform trusted by the largest pharmaceutical companies, today announced registration has opened for its annual AI in Clinical Development Summit, which ...

New indications discovered by applying active machine learning and using samples from the company’s vast biobank of live-cell tumors ...

Clario's Advanced AI-Powered Platform Streamlines Clinical Document Processing to Facilitate Faster Drug Development Timelines PHILADELPH ...

The global AI-enabled drug discovery and clinical trials market size is estimated to reach USD 1,599 by 2030 from 2019 with a CAGR of 24%. The clinical guidelines are not uniform across the studied ...

The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...